In addition, we investigate the differences in LASP1-CXCR4 signaling in breast cancer and CML, as these two tumor entities display different roles for CXCR4, despite comparable overexpression of the receptor binding-partner LASP1. Here, LASP1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.